Cardinal Health (NYSE:CAH) Price Target Raised to $237.00

Cardinal Health (NYSE:CAH) had its price objective boosted by Wells Fargo & Company from $221.00 to $237.00 in a report published on Thursday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

A number of other brokerages have also weighed in on CAH. Argus lifted their target price on shares of Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Leerink Partners set a $240.00 price objective on Cardinal Health in a research report on Tuesday. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Jefferies Financial Group set a $220.00 target price on Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 3rd. Finally, TD Cowen upped their price target on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 3rd. Fourteen analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average target price of $216.33.

Cardinal Health Stock Performance

CAH opened at $212.44 on Thursday. The stock has a market capitalization of $50.48 billion, a PE ratio of 32.04, a price-to-earnings-growth ratio of 1.48 and a beta of 0.65. The stock’s 50 day moving average price is $205.37 and its 200-day moving average price is $174.71. Cardinal Health has a 52-week low of $120.72 and a 52-week high of $215.48.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The firm’s revenue was up 22.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts forecast that Cardinal Health will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were paid a dividend of $0.5107 per share. The ex-dividend date was Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s payout ratio is presently 30.77%.

Hedge Funds Weigh In On Cardinal Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. Integrated Wealth Concepts LLC increased its stake in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after purchasing an additional 280 shares in the last quarter. Jones Financial Companies Lllp increased its position in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Parallel Advisors LLC raised its holdings in Cardinal Health by 8.8% in the 2nd quarter. Parallel Advisors LLC now owns 2,732 shares of the company’s stock worth $459,000 after acquiring an additional 221 shares during the last quarter. MassMutual Private Wealth & Trust FSB lifted its position in Cardinal Health by 3.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock valued at $297,000 after acquiring an additional 62 shares in the last quarter. Finally, Czech National Bank boosted its stake in Cardinal Health by 5.1% during the 2nd quarter. Czech National Bank now owns 58,341 shares of the company’s stock valued at $9,801,000 after purchasing an additional 2,857 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health News Roundup

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent earnings and guidance support continued upside — Cardinal beat EPS and revenue last quarter and set FY‑2026 guidance of $9.65–$9.85, which underpins bullish analyst commentary and sentiment.
• Positive Sentiment: Analyst upgrade and higher price target — Wells Fargo raised its price target to $237 and kept an “overweight” rating, signaling institutional confidence and an ~11.6% upside vs. current levels. Wells Fargo raises PT to $237
• Positive Sentiment: Momentum: 52-week high and positive coverage — Zacks notes CAH reached a 52‑week high and highlights fundamentals that could sustain the run, supporting momentum traders. Cardinal Health Hit a 52 Week High
• Neutral Sentiment: Income/dividend profile noted — A TalkMarkets dividend analysis flags CAH as a major distributor with dividend appeal for income investors, but it’s not a near-term price catalyst. Dividend Stock Analysis: Cardinal Health, Inc.
• Neutral Sentiment: Multiple Zacks pieces highlight CAH for earnings-beat potential and strong interest coverage — useful context for investors but not an immediate trigger. Will Cardinal Beat Estimates Again?
• Neutral Sentiment: General market/quote pages note price action — coverage from Globe and Mail and Economic Times provides market/quote context but no new company developments. Analysts Offer Insights on Healthcare Companies
• Negative Sentiment: Profit-taking and valuation concerns pushing a pullback — after the 52‑week high and analyst hype, investors appear to be trimming positions; intraday volume is below average and the stock carries a relatively rich P/E (~32) and other metrics (negative trailing ROE) that may prompt caution.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.